市场调查报告书
商品编码
1476395
2030 年嗜好大麻市场预测:按产品、管理、化合物、应用、最终用户和地区进行的全球分析Recreational Cannabis Market Forecasts to 2030 - Global Analysis By Product (Transdermal Patches, Concentrates and Other Products), Administration (Topical, Rectal and Inhalation), Compound, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球嗜好大麻市场规模为 19.3 亿美元,预计预测期内复合年增长率为 8.30%,到 2030 年将达到 33.7 亿美元。
嗜好大麻是指为了愉悦和放鬆而使用大麻产品的非药用。它已在世界各地合法化,允许成年人出于娱乐目的购买和消费大麻。使用者通常会寻求精神活性效果,例如欣快感、放鬆和增强的感觉。它有多种形式,包括干燥花、食用品、浓缩液和酊剂,具有不同的功效等级和食用方式。
美国智库皮尤研究中心的一项调查显示,88%的美国成年人支持大麻合法化。具体来说,59%的人支持医疗和娱乐目的合法化,30%支持仅医疗目的合法化。
合法化和监管
合法化和监管是嗜好大麻市场的关键驱动力,为种植、分销和消费提供了框架。合法化消除了与大麻相关的耻辱和犯罪行为,并培养了一个确保产品安全和品质的受监管市场。法规制定了功效、标籤和包装标准,以保护消费者健康并促进负责任的使用。此外,它还创造课税机会,为政府创造收入,并为公共措施提供资金来源。这样的框架也将促进对大麻的医疗和治疗潜力的研究,进一步扩大市场。
课税
嗜好大麻市场的课税限制是指征收过高的税收,阻碍该行业的成长和生存。对大麻产品征收高税将导致价格欺诈,并促使消费者重返非法市场。这不仅违背了监管和安全等合法化的目标,也限制了政府的税收潜力。此外,过度课税可能会阻碍小型企业和企业家,造成进入壁垒,并有利于大公司。找到课税平衡对于培育竞争性和永续的嗜好市场同时确保遵守监管标准至关重要。
大麻种植
嗜好大麻市场是大麻种植的巨大机会。随着许多地区的合法化,需求激增,为高品质大麻产品创造了强劲的市场。种植者可以利用这一点,生产适合消费者偏好的菌株,例如放鬆、创造力或特定的药用功效。此外,水耕和有机栽培等创新栽培技术可以使产品脱颖而出并吸引挑剔的消费者。利用高效、永续种植方法的技术将进一步提高这个快速成长的市场的盈利。
社会耻辱
嗜好大麻市场的社会耻辱威胁源自于对大麻使用根深蒂固的社会观念和偏见。儘管在许多地方已经合法化,但负面的刻板印象仍然存在,并导致使用者受到污名化。这种耻辱表现在许多方面,包括就业和住房方面的歧视、社会排斥和负面标籤。这种态度阻止个人寻求帮助或获得合法大麻产品,从而使边缘化循环永久化。应对这项威胁需要广泛的教育、消除污名化的努力以及旨在促进社会对大麻使用的理解和接受的政策。
COVID-19 的爆发在多个方面对嗜好大麻市场产生了重大影响。最初,药局面临关闭和限制,供应链中断并减少人流。但随着封锁措施的放鬆,许多地区的大麻销售飙升,因为人们寻求缓解压力和替代娱乐。此外,向线上销售和交付服务的转变加速,反映了消费行为的变化。儘管存在这些波动,监管变化和经济不确定性仍影响了该行业的投资和扩张计划。总体而言,COVID-19 凸显了嗜好大麻市场的弹性,同时凸显了适应和创新以应对不确定时期的必要性。
锭剂市场预计将在预测期内成为最大的市场
嗜好大麻市场中锭剂市场的成长归因于消费者可以轻鬆服用药物而不引起注意的便利性和谨慎性。此外,技术的进步促进了精确剂量和控制释放製剂的发展,吸引了寻求可预测和一致效果的消费者。此外,注重健康的消费趋势正在推动对大麻替代方法的需求,例如提供非吸烟选择的锭剂。此外,监管变化和日益合法化扩大了大麻产品(包括锭剂)的供应,促进了市场成长。
个人护理产业预计在预测期内复合年增长率最高
个人护理产业的成长是由于消费者越来越意识到含有大麻的个人保健产品(如乳液、香膏和沐浴炸弹)的潜在治疗功效。这些产品受到追捧,因为据报道它们可以缓解疼痛、减少发炎并提供放鬆效果。此外,随着合法化的蔓延,对 CBD 等非精神活性大麻衍生物的需求激增。此外,社会对大麻的接受度不断提高,导致消费者偏好转向天然和有机成分,进一步增加了大麻个人保健产品的吸引力。
北美嗜好大麻市场的成长是由态度转变、合法化努力和经济潜力共同推动的。随着美国和加拿大的几个州将嗜好大麻的使用合法化,该市场经历了快速增长。这种扩张导致投资增加、创造就业机会和税收增加。此外,消费者对自然和整体疗法的偏好的变化正在推动对大麻产品的需求。不断变化的监管环境和种植技术的进步也促进了市场的成长轨迹。随着企业家和消费者都接受大麻提供的机会和好处,北美嗜好大麻市场继续蓬勃发展。
由于人们对大麻使用的态度不断变化以及合法化努力不断加大,亚太地区嗜好大麻市场的成长尤其迅速。澳洲、纽西兰和东南亚部分地区等国家对休閒大麻的接受度正在提高,导致市场快速成长。此外,该地区人口众多,显示嗜好大麻产品拥有庞大的消费群。此外,随着越来越多的国家寻求监管改革和非犯罪化,投资者越来越被该地区的新兴市场潜力所吸引。大麻相关产品的供应不断扩大以及对替代健康解决方案的需求不断增加将进一步推动这种成长。
According to Stratistics MRC, the Global Recreational Cannabis Market is accounted for $1.93 billion in 2023 and is expected to reach $3.37 billion by 2030 growing at a CAGR of 8.30% during the forecast period. Recreational cannabis refers to the non-medicinal use of cannabis products for enjoyment or relaxation purposes. It's legalized in various regions worldwide, allowing adults to purchase and consume cannabis for recreational purposes. Users typically seek its psychoactive effects, such as euphoria, relaxation, and heightened sensory experiences. Different forms are available, including dried flowers, edibles, concentrates, and tinctures, offering various potency levels and consumption methods.
According to a survey conducted by the Pew Research Center, a US-based think tank, a substantial 88% of U.S. adults expressed a preference for the legalization of marijuana. Specifically, 59% advocate for its legalization for both medical and recreational purposes, while 30% support its legalization solely for medical use.
Legalization and regulation
Legalization and regulation are pivotal drivers of the recreational cannabis market, providing a framework for its cultivation, distribution, and consumption. Legalization removes the stigma and criminality associated with cannabis, fostering a regulated market that ensures product safety and quality. Regulation sets standards for potency, labeling, and packaging, safeguarding consumer health and promoting responsible use. Moreover, it creates opportunities for taxation, generates revenue for governments, and funds public initiatives. This framework also facilitates research into cannabis's medical and therapeutic potential, further expanding its market.
Taxation
Taxation restraint in the recreational cannabis market refers to the imposition of excessive taxes that hinder the growth and viability of the industry. High taxes on cannabis products can lead to inflated prices, driving consumers back to the illegal market. This not only undermines the objectives of legalization, such as regulation and safety, but also limits the tax revenue potential for governments. Moreover, excessive taxation can stifle small businesses and entrepreneurs, creating barriers to entry and favoring larger corporations. Finding a balance in taxation is crucial for fostering a competitive and sustainable recreational cannabis market while ensuring compliance with regulatory standards.
Cannabis cultivation
The recreational cannabis market presents a significant opportunity for cannabis cultivation. With the legalization in many regions, demand has surged, creating a robust market for high-quality cannabis products. Cultivators can capitalize on this by producing strains tailored to consumer preferences, whether it's for relaxation, creativity, or specific medical benefits. Additionally, innovative cultivation techniques, such as hydroponics or organic farming, can differentiate products and attract discerning consumers. Leveraging technology for efficient and sustainable cultivation methods further enhances profitability in this burgeoning market.
Social stigma
The social stigma threat of the recreational cannabis market stems from deeply ingrained societal perceptions and biases surrounding cannabis use. Despite its legalization in many places, negative stereotypes persist, leading to the stigmatization of users. This stigma can manifest in various forms, such as discrimination in employment or housing, social ostracization, and negative labeling. Such attitudes can hinder individuals from seeking help or accessing legitimate cannabis products, perpetuating a cycle of marginalization. Addressing this threat requires widespread education, destigmatization efforts, and policies aimed at promoting understanding and acceptance of cannabis use within society.
The COVID-19 pandemic significantly impacted the recreational cannabis market in several ways. Initially, dispensaries faced closures and restrictions, disrupting supply chains and reducing foot traffic. However, as lockdown measures eased, many regions witnessed a surge in cannabis sales as people sought stress relief and alternative forms of recreation. Additionally, the shift towards online sales and delivery services accelerated, reflecting changing consumer behaviours. Despite these fluctuations, regulatory changes and economic uncertainties affected investments and expansion plans in the industry. Overall, COVID-19 underscored the resilience of the recreational cannabis market while highlighting the need for adaptability and innovation in navigating uncertain times.
The tablets segment is expected to be the largest during the forecast period
The growth of the tablet segment in the recreational cannabis market can be attributed to their convenience and discretion, allowing consumers to easily dose themselves without drawing attention. Additionally, advancements in technology have led to the development of precise dosing and controlled-release formulations, appealing to consumers seeking predictable and consistent effects. Moreover, the trend towards health-conscious consumption has driven demand for alternative methods of cannabis consumption, such as tablets, which offer a smoke-free option. Furthermore, regulatory changes and increasing legalization have expanded the availability of cannabis products, including tablets, driving market growth.
The personal care segment is expected to have the highest CAGR during the forecast period
The growth of the personal care segment can be attributed to an increasing awareness among consumers about the potential therapeutic benefits of cannabis-infused personal care products such as lotions, balms, and bath bombs. These products are being sought after for their reported ability to alleviate pain, reduce inflammation, and provide relaxation. Also, as legalization spreads, there's a burgeoning demand for non-psychoactive cannabis derivatives like CBD, which are often incorporated into personal care items for their purported skin-soothing and anti-inflammatory properties. Additionally, the evolving social acceptance of cannabis has led to a shift in consumer preferences towards natural and organic ingredients, further boosting the appeal of cannabis-infused personal care products.
The growth of the recreational cannabis market in North America has been fueled by a combination of changing attitudes, legalization efforts, and economic potential. With several states in the U.S. and Canada legalizing recreational use, the market has experienced exponential growth. This expansion has led to increased investment, job creation, and tax revenue. Additionally, a shift in consumer preferences towards natural and holistic remedies has driven demand for cannabis products. The evolving regulatory landscape and advancements in cultivation techniques have also contributed to the market's growth trajectory. North America's recreational cannabis market continues to flourish as both entrepreneurs and consumers embrace the opportunities and benefits it offers.
The Asia-Pacific region has seen a notable surge in the recreational cannabis market due to evolving attitudes toward cannabis use and increasing legalization efforts. Countries like Australia, New Zealand, and parts of Southeast Asia are witnessing a growing acceptance of cannabis for leisure purposes, leading to a burgeoning market. Additionally, the region's large population presents a significant consumer base for recreational cannabis products. Moreover, as more nations explore regulatory reforms and decriminalization, investors are increasingly drawn to the potential of this emerging market in the region. This growth is further fueled by the expanding availability of cannabis-related products and the rising demand for alternative wellness solutions.
Key players in the market
Some of the key players in Recreational Cannabis market include 22nd Century Group, Acreage Holdings, Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Cresco Labs, Front Ventures , HEXO Corp, INDIVA, Medical Marijuana, Inc., Organigrams Holding Inc., Perrigo, PharmaCann Inc., STENOCARE A/S , TerrAscend Corp., The Cronos Group, Tilray Inc., Trulieve, Village Farms International Inc and VIVO Cannabis Inc.
In March 2024, Aurora Cannabis Inc. - The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced the availability of medical cannabis pastilles for doctors to prescribe to patients in Australia. The novel product is produced by Aurora and distributed by MedReleaf Australia, a leading distributor of medical cannabis products with the number two position in the Australian market.
In March 2024, Trulieve Cannabis Corp, a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Cocoa Beach, Florida. The new location will carry a wide variety of popular products including Trulieve's portfolio of in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.